'There is no emergency of a third wave that we are rushing for booster doses.' IMAGE: A healthcare worker collects a swab sample of a passenger for the COVID-19 test in the wake of the new......
The country's first indigenous mRNA vaccine candidate developed by Gennova, Pune has received approval from drug regulators to initiate Phase 1/2 human clinical trials, the Department of......
Prime Minister Narendra Modi on Monday held a virtual meeting with three teams working on developing and manufacturing COVID-19 vaccine, and urged them to take extra efforts to inform people......
India's first mRNA platform-based vaccine will remain stable at 2-8 degrees Celsius while Pfizer-BioNTech's vaccine needs minus 70 degrees Celsius and Moderna vaccine can remain stable for six......
Three COVID-19 vaccines, developed by Bharat Biotech, Serum Institute of India and Pfizer, are under active consideration of India's drug regulator and there is hope that early licensure is......